Your Path to Hope Resources

Recurrent glioblastoma, sometimes referred to as glioblastoma multiforme or simplyGBM, stands as one of the most aggressive brain tumors known to medical science. Itis a malignancy that relentlessly invades the brain, presenting a formidable challengefor …

Leptomeningeal Metastases (LM) is sometimes referred to as leptomeningeal cancer,leptomeningeal disease, neoplastic meningitis, or meningeal carcinomatosis. This rarebut serious condition happens when cancer cells spread to the membranes surroundingthe brain and spinal cord.  Leptomeningeal Metastases is …

A brain tumor diagnosis can be overwhelming, but fortunately, various proven FDA-cleared and FDA-approved treatment options are available.

A brain tumor patient will encounter numerous specialists and need to make a multitude of decisions throughout their journey. With these factors and more, navigating cancer care can be overwhelming.  For patients with glioblastoma (GBM), management is even more challenging due to their poor prognosis, feelings of isolation, need for treatment, and cognitive decline associated with this rare and progressive disorder. For these reasons, shared decision-making (SDM) must be integrated into standard practice so that patients’ expectations and goals are considered when discussing and weighing the risks and benefits of treatments.

As I write this, it marks the week, three years ago, that so drastically changed my life. I was 32 years old when I was told that the headaches I had been suffering from for several months were actually being caused by a lesion on my brain and that I would need brain surgery right away to remove the tumor sitting above my right frontal lobe.

Novocure and GT Medical Technologies continue to move forward and make progress in their research to creating a better quality of life for patients and improving survival rates.

It had been two months since I started a new course of chemotherapy, and I tried to imagine the damage it dealt to the tumor in my head.

Learn about a a variety of topics surrounding telehealth options for brain tumor patients.

Written by Jenny Williams (aka ‘Jenguin’) – Head for the Cure Ambassador Watching TV, you’re bound to see one of those commercials for a pharmaceutical drug where they list out the side effects, and somewhere …

Dr. Khagi from UNC Neuro-Oncology Program breaks down a glioblastoma diagnosis from imaging to clinical trials to new research.